AsOf

Recorded or changed on this day 2026-11-08

45,201–45,250 of 46,534 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 806,185,000 United States dollar
Vertex Pharmaceuticals research and development: 806,185,000 United States dollar, claim clm_CA9105114287 · ended · superseded by clm_727E384A5333 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 837,270,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 837,270,000 United States dollar, claim clm_CBAB0AE654C4 · ended · superseded by clm_B82BAA2538E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 6,275,698,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 6,275,698,000 United States dollar, claim clm_CC12F522D151 · ended · superseded by clm_A982731934E0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 699,800,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 699,800,000 United States dollar, claim clm_CCC1584CC243 · ended · superseded by clm_87BE0FC8B08C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -148,233,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -148,233,000 United States dollar, claim clm_CD892C0A824B · ended · superseded by clm_6F9D9EB7890A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 255,755,961 shares
Vertex Pharmaceuticals shares outstanding: 255,755,961 shares, claim clm_CD985C968363 · ended · superseded by clm_09C3E31B05ED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 941,293,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 941,293,000 United States dollar, claim clm_CDABAE46C981 · ended · superseded by clm_01DE6C70A804 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,529,290 shares
Vertex Pharmaceuticals shares outstanding: 257,529,290 shares, claim clm_CDAE1063FD1E · ended · superseded by clm_30424A529FF7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,725,446,000 United States dollar
Vertex Pharmaceuticals total assets: 1,725,446,000 United States dollar, claim clm_CE17430C757C · ended · superseded by clm_DBCB7DA025BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 10,369,100,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 10,369,100,000 United States dollar, claim clm_CEBE7B1AF903 · ended · superseded by clm_BA38CFEB0E56 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 196,371,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 196,371,000 United States…, claim clm_CEDFEA389A43 · ended · superseded by clm_87BBE0E23F91 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · quarterly research and development · 603,100,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 438,737,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 438,737,000 United States dollar, claim clm_D0A8C98B8F52 · ended · superseded by clm_EDB18FEAB098 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 398,080,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 398,080,000 United States dollar, claim clm_D1405FE577D0 · ended · superseded by clm_3D46B58FF11A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -165,890,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -165,890,000 United States dollar, claim clm_D1B891CE165A · ended · superseded by clm_B3AC75D212CF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,604,856,000 United States dollar
Vertex Pharmaceuticals total assets: 2,604,856,000 United States dollar, claim clm_D1DAC76653E3 · ended · superseded by clm_68D80A12D2B9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 14,774,700,000 United States dollar
Vertex Pharmaceuticals total equity: 14,774,700,000 United States dollar, claim clm_D1FB9551C69B · ended · superseded by clm_00AA213A3D85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 236,194,337 shares
Vertex Pharmaceuticals shares outstanding: 236,194,337 shares, claim clm_D207B55FE5A6 · ended · superseded by clm_8D7D5AA15F63 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,165,827,000 United States dollar
Vertex Pharmaceuticals total assets: 2,165,827,000 United States dollar, claim clm_D21E1EE854F6 · ended · superseded by clm_82FAC17B63B7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 16,409,600,000 United States dollar
Vertex Pharmaceuticals total equity: 16,409,600,000 United States dollar, claim clm_D2246EF67C62 · ended · superseded by clm_030CF6670A5D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,322,453,000 United States dollar
Vertex Pharmaceuticals total equity: 1,322,453,000 United States dollar, claim clm_D261B9E53F59 · ended · superseded by clm_6D0B6A2430B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 143,012,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 143,012,000 United States…, claim clm_D2BF7F6D2E9B · ended · superseded by clm_A76FEE254CA5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 756,250,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 756,250,000 United States dollar, claim clm_D372DE4FDD99 · ended · superseded by clm_E053D1ED646F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 255,558,035 shares
Vertex Pharmaceuticals shares outstanding: 255,558,035 shares, claim clm_D3864179769E · ended · superseded by clm_2DB9804ECA5E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 1,538,271,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 1,538,271,000 United States dollar, claim clm_D38659C12AE8 · ended · superseded by clm_05E33637AD96 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 2,096,896,000 United States dollar
Vertex Pharmaceuticals net income: 2,096,896,000 United States dollar, claim clm_D3A2B88BD1F9 · ended · superseded by clm_FE5B5CF4FB84 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,674,700,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,674,700,000 United States dollar, claim clm_D421BB040AD7 · ended · superseded by clm_3F4C3A8A99D1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 17,175,400,000 United States dollar
Vertex Pharmaceuticals total equity: 17,175,400,000 United States dollar, claim clm_D44D3849A57A · ended · superseded by clm_1E5EC8CA7B8E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 10,151,100,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 10,151,100,000 United States dollar, claim clm_D4ECC6686864 · ended · superseded by clm_3876937046B3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 1,003,679,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 1,003,679,000 United States dollar, claim clm_D5FCBE91D068 · ended · superseded by clm_41E7A07E4BD9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 170,434,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 170,434,000 United States…, claim clm_D6506FFCBC0C · ended · superseded by clm_35956A6601A7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 205,649,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 205,649,000 United States dollar, claim clm_D6C88602928F · ended · superseded by clm_6686B23D1227 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 29,574,000 United States dollar
Vertex Pharmaceuticals net income: 29,574,000 United States dollar, claim clm_D6D7CB158831 · ended · superseded by clm_117D40256E77 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -41,631,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -41,631,000 United States dollar, claim clm_D76BCB337804 · ended · superseded by clm_6A661CF6BB52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,551,600 shares
Vertex Pharmaceuticals shares outstanding: 257,551,600 shares, claim clm_D7E4C28F5ECB · ended · superseded by clm_AF5A88F5634C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 653,138,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 653,138,000 United States dollar, claim clm_D8AA2809B20A · ended · superseded by clm_4F89C70F30F6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 224,780,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 224,780,000 United States…, claim clm_D9114AAA14BA · ended · superseded by clm_411488F61069 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 254,830,232 shares
Vertex Pharmaceuticals shares outstanding: 254,830,232 shares, claim clm_D91AA7148A23 · ended · superseded by clm_A2CE75CC8517 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 24,862,300,000 United States dollar
Vertex Pharmaceuticals total assets: 24,862,300,000 United States dollar, claim clm_D95598CEB876 · ended · superseded by clm_0090178AE4A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 9,289,900,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 9,289,900,000 United States dollar, claim clm_DA9B9E142C37 · ended · superseded by clm_D4ECC6686864 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 17,996,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 17,996,000 United States dollar, claim clm_DAC478AD397E · ended · superseded by clm_ED246483C6AB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 602,199,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 602,199,000 United States dollar, claim clm_DAD4C578295B · ended · superseded by clm_2E63C80C1EC9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 2,782,100,000 United States dollar
Vertex Pharmaceuticals operating income: 2,782,100,000 United States dollar, claim clm_DB3896AB26E8 · ended · superseded by clm_EA4DD24E67F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 259,960,062 shares
Vertex Pharmaceuticals shares outstanding: 259,960,062 shares, claim clm_DB51B55830F5 · ended · superseded by clm_BF1FDA0B7CEF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 5,253,394,000 United States dollar
Vertex Pharmaceuticals total equity: 5,253,394,000 United States dollar, claim clm_DBBB2E7ADFB1 · ended · superseded by clm_2E4E3E5F618D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,538,487,000 United States dollar
Vertex Pharmaceuticals total assets: 1,538,487,000 United States dollar, claim clm_DBCB7DA025BF · ended · superseded by clm_6B7C068E138D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 1,407,090,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 1,407,090,000 United States…, claim clm_DC884CD97A0D · ended · superseded by clm_86D501AB2F5C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,027,733,000 United States dollar
Vertex Pharmaceuticals total equity: 1,027,733,000 United States dollar, claim clm_DD677E25C8F6 · ended · superseded by clm_2A4FE21B733E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 3,619,600,000 United States dollar
Vertex Pharmaceuticals net income: 3,619,600,000 United States dollar, claim clm_DD75AE2A6FF1 · ended · superseded by clm_B3A7B0C585DF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 5,069,965,000 United States dollar
Vertex Pharmaceuticals total equity: 5,069,965,000 United States dollar, claim clm_DD7CA9ADDF1C · ended · superseded by clm_DBBB2E7ADFB1 · 1 source (1 primary) · conf 0.95

What the statuses mean